You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Eli Lilly and Company announces dividend for fourth quarter of 2022
18 October 2022 -

Eli Lilly and Company (NYSE: LLY), a US-based pharmaceutical company, on Monday announced a dividend for the fourth quarter of 2022.

The company has declared a dividend of USD0.98 per share on outstanding common stock.

The dividend will be paid to shareholders of record as of 15 November 2022, on 9 December 2022.

Login
Username:

Password:


Related Headlines

Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan

Perrigo announces quarterly dividend

Eli Lilly announces Q4 2023 dividend

Moderna and CEPI partner to accelerate mRNA vaccine development

OptiBiotix secures license agreement with Tata Chemicals for Indian market

Poolbeg Pharma announced collaboration with biopharmaceutical company to develop oral drug for metabolic condition

Pharnext evaluates offers caluing Charcot-Marie-Tooth disease drug candidate at over EUR250m

Transgene and BioInvent evaluate BT-001 oncolytic virus in combination trial with KEYTRUDA

Novartis completes Sandoz Spin-off

CVS Health declares quarterly dividend

Abbott announces quarterly common dividend

AbbVie Inc announces quarterly cash dividend

Zimmer Biomet Holdings announces quarterly cash dividend

Quest Diagnostics announces quarterly cash dividend

Seres Therapeutics provides business updates and reports Q2 2023 financial results

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023